<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-pharmaceutics-13-00573">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Quave</surname>
    <given-names>C.L.</given-names>
   </name>
   <name>
    <surname>Est√©vez-Carmona</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Compadre</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Hobby</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hendrickson</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Beenken</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Smeltzer</surname>
    <given-names>M.S.</given-names>
   </name>
  </person-group>
  <article-title>Ellagic acid derivatives from 
   <italic>Rubus ulmifolius</italic> inhibit 
   <italic>Staphylococcus aureus</italic> biofilm formation and improve response to antibiotics
  </article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e28737</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0028737</pub-id>
  <?supplied-pmid 22242149?>
  <pub-id pub-id-type="pmid">22242149</pub-id>
 </element-citation>
</ref>
